Peking university Cancer Hospital

Beijing, Beijing Municipality 100142

2 studies enrolling now · 5 studies all time

What they study most

Advanced Solid Tumors, Colorectal Cancer, Gastric Cancer, HER2 Exon 20 Mutation, Locally Advanced or Metastatic Solid Tumors, Lymphomas, Non-small Cell Lung Cancer, Non-squamous NSCLC, Pancreatic Cancer

Studies at this site

• A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors — Recruiting now
• A Study of ASKG915 in Patients With Selected Advanced Solid Tumors. — Recruiting now
• Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy — Completed
• eXalt3: Study Comparing X-396 (Ensartinib) to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients — Running, not enrolling
• CAR T Cells Targeting CD30 Positive Lymphomas (4SCAR30273) — Status unconfirmed